Maravai LifeSciences ticks higher amid renewed takeover speculation
May 10, 2023 2:08 PM ETMaravai LifeSciences Holdings, Inc. (MRVI)DHR, SARTFBy: Joshua Fineman, SA News Editor
Luis Alvarez/DigitalVision via Getty Images
- Maravai LifeSciences (NASDAQ:MRVI) briefly spiked up 9.5% and is now up 1% at least partly amid a report about renewed takeover speculation.
- There's some speculation that Maravai (MRVI) has drawn takeover interest, according to a Betaville "uncooked" alert. It's not clear which company appears to be interested in Maravai. Danaher (DHR) is said to have previously shown interest in the company.
- The latest report comes after Reuters reported last February that German lab supplies vendor Sartorius (OTCPK:SARTF) made an $11B acquisition offer for the U.S.-based life sciences company. Betaville also reported last May that the Maravai (MRVI) was working with a banker amid the takeover interest.
- Shares of Maravai (MRVI) dropped 13% on Tuesday after company lowered its 2023 financial guidance and Goldman downgraded the stock to neutral.